Williamstown, MA -- (SBWIRE) -- 12/11/2009 -- This analysis examines the historical and forecast performance for Allergan in the Rx pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

* Benchmark Allergan's performance against key rivals in the prescription pharmaceutical sector
* Assess how the key Botox franchise stands up to the global recession and the arrival of further competitors
* Analyze the impact of Allergan's acquisition of Esprit Pharma in 2007, namely its movement into the urology therapy market


Partial Table of Contents:
-- Full ToC is available at http://www.fastmr.com/catalog/product.aspx?productid=43011&dt=t

ABOUT DATAMONITOR HEALTHCARE

About the PharmaVitae team
Chapter 1 About this profile
PharmaVitae Explorer database
Chapter structure
Executive summary
Quarterly news update
Company introduction
Company sales
Company financials
Key products and competitors
Data sourcing
Sales data
Analyst consensus
Chapter 2 Executive summary
Key findings
Prescription pharmaceutical sales and growth rate performance, 2002-14
Financial performance, 2002-14
Allergan: PharmaVitae forecasts at a glance
Strategic insight
Allergan is highly dependent upon sales of Botox
Botox plays a central role in Allergan's synergistic expansion
SWOT analysis
Strengths
Weaknesses
Opportunities
Threats
Table of Contents
Table of figures
Chapter 3 Quarterly news update
Product developments
Deals and alliances
Product deals
Technology deals
M&A activity
Company announcements
Future product milestones
Chapter 4 Company introduction
Key findings
Background
Key corporate developments
M&A history
Acquired by SmithKline Beckman
Allergan spun-out from SmithKline Beckman
Acquisition of Oculinum
Divestment of Allergan Humphrey
Divestment of contact lens businesses
Five acquisitions were made in and around 1995
Allergan Specialty Therapeutics spun-out
Allergan Specialty Therapeutics re-acquired
Bardeen Sciences set-up
Advanced Medical Optics spun-out
Bardeen Sciences acquired
Oculex acquired
Acquistition of Inamed
Groupe Corneal Laboratoires acquired
EndoArt acquired
Acquisition of Esprit Pharma
Current corporate structure
Pharmaceuticals
Allergan Medical
Chapter 5 Company sales
Key findings
Prescription pharmaceutical sales and growth rate analysis, 2002-14
Product analysis
Product analysis, 2002-08
Product analysis, 2008-14
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Explanation of launch/core/expiry analysis
Launch analysis, 2008-14
Core analysis, 2008-14
Expiry analysis, 2008-14
Launch/core/expiry configuration, 2008-14
Molecule type analysis
Externalization analysis
Chapter 6 Company financials
Key findings
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08
Operating costs and profit analysis
Operating costs and profit analysis, 2002-08
Operating cost ratio and profit margin analysis, 2002-08
Operating cost ratio and profit margin analysis, 2008-14
Operating costs and profit analysis, 2008-14
Chapter 7 Key products and competitors
Key findings
Overview
Central nervous system
Botox
Overview
Sales forecast
Other (ophthalmology)
Restasis
Overview
Sales forecast
Lumigan franchise
Overview
Sales forecast
Alphagan franchise
Overview
Sales forecast
Ozurdex
Overview
Sales forecast
Ozurdex offers significant benefits over the standard of care
Other (skin care)
Latisse
Overview
Sales forecast
Chapter 8 Appendix
R&D pipeline
Reconciliation with reported figures
References
Abbreviations
Exchange rates
About Datamonitor
About Datamonitor Healthcare
Datamonitor consulting
Disclaimer
List of Tables
Table 1: Allergan - PharmaVitae forecasts at a glance

For more information or to purchase this report, go to http://www.fastmr.com/catalog/product.aspx?productid=43011

About Datamonitor
The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.